A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
The purpose of the study is to determine the safety and efficacy of two dosing regimens of daclizumab in simultaneous kidney/pancreas transplant recipients.
Epistemonikos ID: ca512af3e254a8c64cfcad353c1fcdbff00c2bcd
First added on: May 04, 2024